Mesothelin-specific CAR-T Cell Therapy with HLA-gated Safety Mechanism Selectively Kills Tumor Cells

CAR-T Cells: Engineered Cancer Killers, Mechanism of ActionПодробнее

Dr. Adusumilli on Autologous Mesothelin-Targeted CAR T Cells in Advanced Solid TumorsПодробнее

Dr. John Mullinax at SITC 2022: CAR T therapy with ovarian cancer.Подробнее

CAR T Cells: Beating Cancer with the Immune SystemПодробнее

CAR T Cell Therapy Explained (Animation) | City of HopeПодробнее

Updates in targeting mesothelin-expressing solid tumorsПодробнее

Identifying patients with solid tumors for HLA loss of heterozygosityПодробнее

Tmod cellular logic gate as a solution to on-target, off-tumor toxicity in CAR-T for solid tumorsПодробнее

Cancer Immunotherapy Workshop 2021 – Engineering Remotely Controllable CAR T CellsПодробнее

Activated T cell attacks a cancer cellПодробнее

The Multiple Myeloma: CAR-TПодробнее

CAR T-cell Therapy: A game changer for #cancertreatment #immunotherapy #cancerПодробнее

Label-free Live Cell Imaging: Activated T-Cell Killing Cancer CellПодробнее

HLA’s Future Impact on Allogeneic Cell Therapy DevelopmentПодробнее

How can Elicera’s iTANK technology boost CAR-T cell therapies?Подробнее

Updates in CAR T Cell TherapiesПодробнее

BASECAMP-1: developing Tmod CAR T-cell therapy for solid tumorsПодробнее

What is CAR T-Cell Therapy: How Does this CANCER Treatment Work?Подробнее

Engineered T Cells for CancerПодробнее